LyGenesis logo — company profile

LyGenesis

Founded 2017 United States Pittsburgh, United States 8 employees Series A Total: $45.73M Biotechnology

General Information

Company Name LyGenesis
Founded Year 2017
Location United States Pittsburgh, United States +1
Employees 8
Industries Biotechnology
Funding Stage Series A
Social

Get notified when LyGenesis moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LyGenesis

LyGenesis is a biotechnology company founded in 2017 with a groundbreaking organ regeneration technology platform. Their innovative approach involves using a patient’s lymph nodes as bioreactors to regrow functioning ectopic organs, with a lead preclinical program focused on liver regeneration for patients with end-stage liver disease. The company's potential therapeutic targets for organ regeneration also include the thymus, pancreas, and kidney. Currently, LyGenesis is headquartered in Pittsburgh, Pennsylvania and has received a significant $19.00M Series A investment from Juvenescence and Prime Movers Lab on 24 October 2023.

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 2
Investor Investor
24 Oct 2023
Venture Round •••••• - 12 Oct 2023
Convertible Note •••••• 2
Investor Investor
30 Dec 2020
Debt Financing •••••• 2
Investor Investor
21 Oct 2019
Series A •••••• 1
Investor
09 May 2018

LyGenesis Alternatives & Competitors

LyGenesis vs

Our Vision: We challenge ourselves and others every day to realize Arizona’s potential to save and i...

259 employees
Health Care
LyGenesis vs
XVIVO Abdominal
XVIVO Abdominal The Netherlands

We believe in an extended life of organs. Nobody should die waiting for a new organ.

Series Unknown
11 employees
Health Care
LyGenesis vs
OrganOx
OrganOx United Kingdom

Our mission is to save lives by making every organ count

Series Unknown
250 employees
Health Care, Medical Devices

FAQ About LyGenesis

LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end stage liver disease. Other t...
LyGenesis was founded in 2017.
LyGenesis is headquartered in Pittsburgh, United States.
LyGenesis operates in the following industries: Biotechnology.
LyGenesis has approximately 8 employees.
LyGenesis has completed 5 funding rounds, raising a total of $45.73M. The latest funding stage is Series A.
Top alternatives and competitors to LyGenesis include Donor Network of Arizona, XVIVO Abdominal, OrganOx, Hexaell Biotech, vitOrgan Arzneimittel GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LyGenesis and Donor Network of Arizona are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LyGenesis and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes